Search Result "XDR"
Safety and Efficacy of Thioridazine as Salvage Therapy in Indian Patients with XDR-TB
Journal: Recent Patents on Anti-Infective Drug Discovery
Volume: 6 Issue: 2 Year: 2011 Page: 88-91
Author(s): Zarir F. Udwadia, Tiyas Sen, Lancelot M. Pinto
XDR-TB, What is it; How is it Treated; and why is Therapeutic Failure so High?
Journal: Recent Patents on Anti-Infective Drug Discovery
Volume: 6 Issue: 2 Year: 2011 Page: 77-83
Author(s): Stephen H. Gillespie, Kasha Singh
Therapy of XDR TB with Thioridazine a Drug Beyond Patent Protection but Eligible for Patent “As New Use”
Journal: Recent Patents on Anti-Infective Drug Discovery
Volume: 5 Issue: 2 Year: 2010 Page: 109-114
Author(s): Leonard Amaral, Joseph Molnar
Stem Cells in MDR-TB and XDR - TB
Journal: Current Respiratory Medicine Reviews
Volume: 10 Issue: 4 Year: 2014 Page: 238-240
Author(s): Vijay K. Arora,Paramjit S. Dhot,P. Singhal
The Evolution of Extensively Drug Resistant Tuberculosis (XDR-TB): History, Status and Issues for Global Control
Journal: Infectious Disorders - Drug Targets
Volume: 7 Issue: 2 Year: 2007 Page: 73-91
Author(s): Robert C. Goldman, Kevin V. Plumley, Barbara E. Laughon
Promising Therapy of XDR-TB/MDR-TB with Thioridazine an Inhibitor of Bacterial Efflux Pumps
Journal: Current Drug Targets
Volume: 9 Issue: 9 Year: 2008 Page: 816-819
Author(s): L. Amaral, M. Martins, M. Viveiros, J. Molnar, J. E. Kristiansen
An Experience with Delamanid in an XDR TB Case â Case Report
Journal: Infectious Disorders - Drug Targets
Volume: 21 Issue: 4 Year: 2021 Page: 637-639
Author(s): Nimitha Mohan,Manharpreet Kaur,Lipika Singhal,Varinder Saini,Jagdish Chander
Clinical Pharmacology and Lesion Penetrating Properties of Second- and Third-Line Antituberculous Agents Used in the Management of Multidrug-Resistant (MDR) and Extensively-Drug Resistant (XDR) Tuberculosis
Journal: Current Clinical Pharmacology
Volume: 5 Issue: 2 Year: 2010 Page: 96-114
Author(s): Veronique Dartois, Clifton E. Barry
Thioridazine: Alternative and Potentially Effective Therapy of the XDRTB Patient
Journal: Letters in Drug Design & Discovery
Volume: 8 Issue: 2 Year: 2011 Page: 130-132
Author(s): Leonard Amaral, Marta Martins, Miguel Viveiros
Effective Therapy with the Neuroleptic Thioridazine as an Adjunct to Second Line of Defence Drugs, and the Potential that Thioridazine Offers for New Patents that Cover a Variety of “New Uses”
Journal: Recent Patents on Anti-Infective Drug Discovery
Volume: 6 Issue: 2 Year: 2011 Page: 84-87
Author(s): Leonard Amaral, Miguel Viveiros, Joseph Molnar, Jette E. Kristiansen